Prostate Cancer - Results from #2240

A Clinical Role of PET-MRI in Prostate Cancer ? September 4, 2023

Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC. September 4, 2023

Differentiation of patients with and without prostate cancer using urine 1 H NMR metabolomics. September 4, 2023

Characterization of Google Search Volumes and Trends From 2004 to 2021 for Diagnosis and Treatment of Locally Advanced Prostate Cancer. September 4, 2023

Development and Validation of a New BAG-1L Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. September 4, 2023

Impact of exercise on continence in prostate cancer patients post robotic assisted radical prostatectomy: a systematic review. September 4, 2023

LSD1 Promotes Prostate Cancer Reprogramming by Repressing TP53 Signaling Independently of Its Demethylase Function September 1, 2023

Global research status and hotspots of radiotherapy for prostate cancer: a bibliometric analysis based on Web of Science from 2010-2022. September 1, 2023

The influence of secondary resection using NeuroSAFE-technique on sexual function in unilateral nerve-sparing robot-assisted laparoscopic prostatectomies. September 1, 2023

Influencing Best Practices for Genomic and Germline Testing in Urology. September 1, 2023

Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer. September 1, 2023

Plain language summary: Does the amount of time it takes for prostate-specific antigen to double affect how long men with nonmetastatic castration-resistant prostate cancer live and their healthcare costs? September 1, 2023

Trends in prostate cancer screening in the pre- and peri-COVID-19 Pandemic period. September 1, 2023

Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy. September 1, 2023

A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. September 1, 2023

Prostate-specific membrane antigen-based imaging for stereotactic irradiation of low-volume progressive prostate cancer: a single-center experience. August 31, 2023

First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. August 31, 2023

Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer. August 31, 2023

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment. August 31, 2023

In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. August 31, 2023

Page 113 of 1439